Sort
130,381 grants matching “hiv”
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,297,094Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2021 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,297,071Sandra Klocke · Nebraska St Dept Of Health & Human Servs · U62 · FY2012 · PS
Harnessing Data Science to Promote Equity in Injury and Surgery for Africa
$1,297,054Alain Mefire Chichom · University Of Buea · U54 · FY2022 · TW
Ty Element Retrotransposition in Saccharomyces cerevisiae
$1,296,768David J. Garfinkel · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Development of multi-modal single-cell technology to dissect epitope specificity to HIV
$1,296,133Steven Edward Bosinger · Emory University · U24 · FY2024 · AI
Nonhuman Primate Trials
$1,296,052Elizabeth Strobert · Emory University · P01 · FY2011 · AI
Long Acting Film Technology for Contraception and HIV Prevention (LATCH)
$1,295,960Lisa C Rohan · Magee-Women'S Res Inst And Foundation · R61 · FY2021 · AI
SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNIT
$1,295,930Public Health Foundation Enterprises · U01 · FY2001 · AI
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSM
$1,295,482Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2012 · DA
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,295,221Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
CPTR - Mass Spectrometry Unit
$1,295,034Lisa Jenkins · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
STRENGTHENING HIV COUNSELOR TRAINING IN THE REPUBLIC OF UGANDA
$1,295,000Alex Coutinho · Aids Support Organization (Taso) · U62 · FY2009 · PS
SBIR Phase II: Rapid Blood Cleansing Device to Combat Infection
$1,294,999Sinead E Miller · Path Ex · · FY2018 · TIP
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,294,431Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2022 · AI
COLLABORATIVE RESEARCH ON DRUG ABUSE
$1,294,179University Of California Los Angeles · P01 · FY2003 · DA
GH11-1151, (S Africa) HIV EVALUATION ACTIVITIES WITH HIGH-RISK, UNDERSERVED POP
$1,293,880Tim Lane · University Of California, San Francisco · U2G · FY2014 · GH
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
$1,293,876Rafick-Pierre Sekaly · Emory University · P01 · FY2023 · AI
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$1,293,832Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Mechanisms Of Action Of Cocaine
$1,293,676Richard B Rothman · National Institute On Drug Abuse · Z01 · FY2007 · DA
Native Mass Spectrometry Guided Structural Biology Center
$1,293,476Vicki H Wysocki · Ohio State University · RM1 · FY2024 · GM
Mexican Family Culture & Substance Use Risk & Resilience
$1,292,712Richard W Robins · University Of California At Davis · R01 · FY2014 · DA
SPECIALIZED CONTRACEPTIVE DEVELOPMENT RESEARCH CENTER
$1,292,399Population Council · U54 · FY2001 · HD
Crosstalk Among Oral & Gastrointestinal Soluble Innate Factors, HIV, & Microbes
$1,292,217Daniel Malamud · New York University · U19 · FY2010 · DE
Development of strategies to achieve immunoprotection against Cryptosporidiosis
$1,292,121Saul R Tzipori · University Of Maryland Baltimore · U19 · FY2014 · AI
AIDS CLINICAL TRIALS UNIT
$1,291,903Andrew Zolopa · Stanford University · U01 · FY2006 · AI